Gregory W. Gin

Corporate Officer/Principal presso EVC Group, Inc.

Health Technology

Profilo

Gregory W.
Gin is currently a Principal at EVC Group, Inc. He previously worked as Director-Investor Relations at Genta, Inc., Investor Relations Contact at Edge Therapeutics, Inc., and Investor & Media Contact at Affimed NV.

Posizioni attive di Gregory W. Gin

Società	Posizione	Inizio
EVC Group, Inc.	Corporate Officer/Principal	-

Tutte le posizioni attive di Gregory W. Gin

Precedenti posizioni note di Gregory W. Gin

Società	Posizione	Fine
Edge Therapeutics, Inc. Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.	Contatto Relazioni con gli Investitori	-
AFFIMED N.V.	Contatto Relazioni con gli Investitori	-
Genta, Inc. Genta, Inc. Pharmaceuticals: MajorHealth Technology Genta, Inc. is in the process of bankruptcy. The company formerly engages in pharmaceutical research and development. Genta was founded on February 4, 1988 and is headquartered in Berkeley Heights, NJ.	Public Communications Contact	-

Vedi nel dettaglio l'esperienza di Gregory W. Gin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Gregory W. Gin

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
AFFIMED N.V.	Health Technology

Aziende private	3
Genta, Inc. Genta, Inc. Pharmaceuticals: MajorHealth Technology Genta, Inc. is in the process of bankruptcy. The company formerly engages in pharmaceutical research and development. Genta was founded on February 4, 1988 and is headquartered in Berkeley Heights, NJ.	Health Technology
EVC Group, Inc.
Edge Therapeutics, Inc. Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.	Health Technology

Vedi le connessioni aziendali

Borsa valori
Insiders
Gregory W. Gin